DE19519404A1 - Body deodorant - Google Patents
Body deodorantInfo
- Publication number
- DE19519404A1 DE19519404A1 DE1995119404 DE19519404A DE19519404A1 DE 19519404 A1 DE19519404 A1 DE 19519404A1 DE 1995119404 DE1995119404 DE 1995119404 DE 19519404 A DE19519404 A DE 19519404A DE 19519404 A1 DE19519404 A1 DE 19519404A1
- Authority
- DE
- Germany
- Prior art keywords
- water
- deodorant
- atoms
- body deodorant
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002781 deodorant agent Substances 0.000 title claims abstract description 38
- 229920005862 polyol Polymers 0.000 claims abstract description 14
- -1 cationic phospholipid Chemical class 0.000 claims abstract description 13
- 150000003077 polyols Chemical class 0.000 claims abstract description 13
- 239000004094 surface-active agent Substances 0.000 claims abstract description 11
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 10
- 239000000126 substance Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 108090000371 Esterases Proteins 0.000 claims abstract description 5
- 150000001298 alcohols Chemical class 0.000 claims abstract description 5
- 150000008131 glucosides Chemical class 0.000 claims abstract description 5
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 5
- 239000007921 spray Substances 0.000 claims abstract description 4
- HOSGXJWQVBHGLT-UHFFFAOYSA-N 6-hydroxy-3,4-dihydro-1h-quinolin-2-one Chemical group N1C(=O)CCC2=CC(O)=CC=C21 HOSGXJWQVBHGLT-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229930182478 glucoside Natural products 0.000 claims abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 15
- 239000004480 active ingredient Substances 0.000 claims description 13
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 4
- 150000001450 anions Chemical class 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 4
- ORXJMBXYSGGCHG-UHFFFAOYSA-N dimethyl 2-methoxypropanedioate Chemical compound COC(=O)C(OC)C(=O)OC ORXJMBXYSGGCHG-UHFFFAOYSA-N 0.000 claims description 3
- 238000006384 oligomerization reaction Methods 0.000 claims description 3
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 125000004945 acylaminoalkyl group Chemical group 0.000 claims description 2
- 229910052783 alkali metal Chemical group 0.000 claims description 2
- 150000001340 alkali metals Chemical group 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 229920000570 polyether Polymers 0.000 claims description 2
- 230000001998 anti-microbiological effect Effects 0.000 claims 1
- 239000008365 aqueous carrier Substances 0.000 claims 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 11
- 230000000845 anti-microbial effect Effects 0.000 abstract description 9
- 239000013543 active substance Substances 0.000 abstract description 4
- 239000004599 antimicrobial Substances 0.000 abstract description 4
- 230000001877 deodorizing effect Effects 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 229930182470 glycoside Natural products 0.000 description 4
- 150000002338 glycosides Chemical group 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- BZANQLIRVMZFOS-ZKZCYXTQSA-N (3r,4s,5s,6r)-2-butoxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound CCCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O BZANQLIRVMZFOS-ZKZCYXTQSA-N 0.000 description 2
- VAJVDSVGBWFCLW-UHFFFAOYSA-N 3-Phenyl-1-propanol Chemical compound OCCCC1=CC=CC=C1 VAJVDSVGBWFCLW-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 150000004287 bisbiguanides Chemical class 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- WEYVVCKOOFYHRW-UHFFFAOYSA-N usnic acid Chemical compound CC12C(=O)C(C(=O)C)=C(O)C=C1OC1=C2C(O)=C(C)C(O)=C1C(C)=O WEYVVCKOOFYHRW-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 240000007673 Origanum vulgare Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000006359 acetalization reaction Methods 0.000 description 1
- FRTNIYVUDIHXPG-UHFFFAOYSA-N acetic acid;ethane-1,2-diamine Chemical class CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.NCCN FRTNIYVUDIHXPG-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 150000003611 tocopherol derivatives Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- 238000003420 transacetalization reaction Methods 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940004858 usnic acid Drugs 0.000 description 1
- ICTZCAHDGHPRQR-UHFFFAOYSA-N usnic acid Natural products OC1=C(C)C(O)=C(C(C)=O)C2=C1C1(C)C(O)=C(C(=O)C)C(=O)C=C1O2 ICTZCAHDGHPRQR-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 150000003754 zirconium Chemical class 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
Abstract
Description
Die Erfindung betrifft wäßrige Zubereitungen zur Körperdeodorierung, die flüssig, klar oder transparent und kältestabil und von flüchti gen Lösungsmitteln weitgehend oder ganz frei sind.The invention relates to aqueous preparations for body deodorization, the liquid, clear or transparent and cold-stable and from volatile solvents are largely or completely free.
Zubereitungen zur Körperdeodorierung werden üblicherweise als Stift präparate, Roll-on-Formulierungen oder als Aerosol-Sprays angeboten. Dabei werden zunehmend Produkte bevorzugt, die in Roll-on-Behältern oder in Pumpensprays ohne Aerosoltreibgas verpackt sind. Für diesen Zweck sind bisher überwiegend alkoholische und wäßrig-alkoholische Zubereitungen mit relativ hohen Gehalten an niederen Alkoholen ein gesetzt worden.Preparations for body deodorization are usually used as a stick preparations, roll-on formulations or as aerosol sprays. Products that are in roll-on containers are increasingly preferred or are packaged in pump sprays without aerosol propellant. For this So far, the main purpose has been alcoholic and aqueous-alcoholic Preparations with relatively high levels of lower alcohols been set.
Man möchte aber auch den Gehalt an flüchtigen organischen Substanzen in solchen Zubereitungen senken und wenn möglich ganz vermeiden. Das bedingt jedoch erhebliche Probleme bei der klaren und lagerstabilen Einarbeitung der Wirkstoffe und Duftstoffe.But you also want the content of volatile organic substances lower in such preparations and avoid them if possible. The however, causes considerable problems with the clear and storage-stable Incorporation of active ingredients and fragrances.
Es bestand daher die Aufgabe, ein wäßriges, flüssiges Deodorans vor zuschlagen, das klar oder transparent und kältestabil sowie von flüchtigen Lösungsmitteln weitgehend oder ganz frei ist. The task was therefore to provide an aqueous, liquid deodorant slam that clear or transparent and cold stable as well as from volatile solvents is largely or completely free.
Diese Aufgabe wurde erfindungsgemäß gelöst durch ein wäßriges Kör perdeodorans, das einen deodorierenden Wirkstoff in einem wäßrigen Träger enthält, der als Trägerkomponenten Wasser und (bezogen auf das gesamte Deodorans) 10 bis 20 Gew.-% eines wasserlöslichen Po lyols aus der Gruppe der Polyole mit 2 bis 9 C-Atomen und 2 bis 6 Hydroxylgruppen und der Polyetherpolyole mit Molekulargewichten bis 1000, die durch Anlagerung von Ethylenoxid und/oder Propylenoxid an solche Polyole erhältlich sind, und 0,1 bis 10 Gew.-% eines wasser löslichen Tensids enthält und dessen pH-Wert auf einen Wert zwischen 3 und 6 eingestellt ist.This object was achieved according to the invention by an aqueous body perdeodorans, which is a deodorant active in an aqueous Contains carrier, the carrier components water and (based on the entire deodorant) 10 to 20 wt .-% of a water-soluble Po lyols from the group of polyols with 2 to 9 carbon atoms and 2 to 6 Hydroxyl groups and the polyether polyols with molecular weights up 1000 by the addition of ethylene oxide and / or propylene oxide such polyols are available, and 0.1 to 10 wt .-% of a water contains soluble surfactant and its pH to a value between 3 and 6 is set.
Als wäßriges Körperdeodorans wird dabei bevorzugt eine Zubereitung verstanden, die weniger als 5 Gew.-% flüchtiger Lösungsmittel, ins besondere weniger als 5 Gew.-% niederer Alkohole mit 1 bis 3 C-Ato men enthält. Bevorzugt ist das erfindungsgemäße Körperdeodorans frei von flüchtigen Lösungsmitteln.A preparation is preferred as the aqueous body deodorant understood that less than 5 wt .-% volatile solvent, ins especially less than 5% by weight of lower alcohols with 1 to 3 carbon atoms contains men. The body deodorant according to the invention is preferably free of volatile solvents.
Als wasserlösliche Polyole eignen sich z. B. Ethylenglycol, Propylen glycol, Glycerin, Diethylenglycol, Diglycerin, Sorbit, Methylgluco sid, Butylglucosid, Anlagerungsprodukte von 10 bis 20 Mol Ethylen oxid an Methylglucosid oder Butylglucosid, Polyglycerin, Polyethy lenglycole und Anlagerungsprodukte von Ethylenglycol an Polypropy lenglycole. Als wasserlöslich werden dabei alle Polyole oder Poly etherpolyole verstanden, die bei 20°C zu wenigstens 10 Gew.-% in Wasser klar löslich sind und dabei flüssige Lösungen bilden. Be vorzugt ist als wasserlösliches Polyol 1,2-Propylenglycolin den er findungsgemäßen Körperdeodorantien enthalten. Es können aber auch Mischungen aus den genannten Polyolen eingesetzt werden.Suitable water-soluble polyols are, for. B. ethylene glycol, propylene glycol, glycerin, diethylene glycol, diglycerin, sorbitol, methylgluco sid, butyl glucoside, adducts of 10 to 20 moles of ethylene oxide on methyl glucoside or butyl glucoside, polyglycerin, polyethylene lenglycole and adducts of ethylene glycol with polypropy lenglycole. All polyols or poly become water-soluble understood ether polyols that at 20 ° C to at least 10 wt .-% in Water are clearly soluble and thereby form liquid solutions. Be preference is given to the water-soluble polyol 1,2-propylene glycol contain body deodorants according to the invention. But it can also Mixtures of the polyols mentioned are used.
Als wasserlösliches Tensid kann jedes Tensid verwendet werden, das eine Wasserlöslichkeit von wenigstens 1 Gew.-% in Wasser bei 20°C aufweist. Bei der Tensidauswahl ist jedoch darauf zu achten, daß keine Beeinträchtigungen der antimikrobiellen, deodorierenden Wir kung der Deodorantwirkstoffe auftreten. Obwohl nichtionogene Tenside insbesondere wegen ihrer guten emulgierenden und solubilisierenden Eigenschaften bevorzugt sind, können doch bei bestimmten antimikro biellen Stoffen Wirkungsverluste auftreten. Besonders bevorzugt eig nen sich erfindungsgemäß als Tensid Alkyl-(oligo)-glucoside der For mel R¹O(C₆H₁₀O₅)nH, in der R¹ eine Alkylgruppe mit 8 bis 16 C-Ato men, (C₆H₁₀O₅) ein Glucosidrest und n, dessen Oligomerisationsgrad, 1 bis 10 ist. Der Glycosidrest ist bevorzugt von Glucose abgeleitet.Any surfactant which has a water solubility of at least 1% by weight in water at 20 ° C. can be used as the water-soluble surfactant. When selecting the surfactant, however, care must be taken to ensure that there is no impairment of the antimicrobial, deodorant effect of the deodorant active ingredients. Although nonionic surfactants are preferred because of their good emulsifying and solubilizing properties, certain antimicrobial substances may lose their effectiveness. Particularly preferably, according to the invention, suitable surfactants are alkyl (oligo) glucosides of the formula R¹O (C₆H₁₀O₅) n H, in which R¹ is an alkyl group having 8 to 16 C-atoms, (C₆H₁₀O₅) a glucoside residue and n, the degree of oligomerization of which Is 1 to 10. The glycoside residue is preferably derived from glucose.
Alkylglycoside, ihre Herstellung und Verwendung als oberflächenak tive Stoffe sind beispielsweise aus DE 19 43 689 oder aus DE 38 27 543 bekannt. Ihre Herstellung erfolgt beispielsweise durch Umsetzung von Glucose oder von Oligosacchariden mit primären Alko holen mit 8 bis 22 C-Atomen oder durch Umacetalisierung von Stärke mit z. B. niederen Alkoholen und erneute Umacetalisierung mit dem C₈-C₂₂-Fettalkohol. Bezüglich des Glycosidrestes gilt, daß sowohl Monoglycoside, bei denen ein cyclischer Zuckerrest glycosidisch an den Fettalkohol gebunden ist, als auch oligomere Glycoside mit einem Oligomerisationsgrad bis etwa 10 geeignet sind. Der mittlere Oligo merisationsgrad ergibt sich aus den molaren Anteilen der einzelnen Oligomeren durch Division der Summe der Struktureinheiten durch die Summe der Moleküle (vgl. Principles of Polymer Chemistry, Paul J. Flory, Cornell University Press, Ithaca, New York 1953, Seite 35-36).Alkyl glycosides, their preparation and use as surface ac active substances are for example from DE 19 43 689 or DE 38 27 543 known. They are manufactured, for example, by Reaction of glucose or of oligosaccharides with primary alcohol fetch with 8 to 22 carbon atoms or by transacetalization of starch with z. B. lower alcohols and re-acetalization with the C₈-C₂₂ fatty alcohol. Regarding the glycoside residue, both Monoglycosides, in which a cyclic sugar residue is glycosidic the fatty alcohol is bound, as well as oligomeric glycosides with a Degree of oligomerization up to about 10 are suitable. The middle oligo Degree of merger results from the molar proportions of the individual Oligomers by dividing the sum of the structural units by the Sum of molecules (see Principles of Polymer Chemistry, Paul J. Flory, Cornell University Press, Ithaca, New York 1953, page 35-36).
Die Verwendung von Alkyl-(oligo)-glycosiden in den erfindungsgemäßen Deodorantien führt bei zahlreichen deodorierenden Wirkstoffen, z. B. bei kationischen Verbindungen und bei den Bis-biguaniden (z. B. Chlorhexidin-gluconat) sogar zu einer synergistisch gesteigerten deodorierenden Wirkung, die es erlaubt, solche Deodorant-Wirkstoffe in besonders niedrigen und physiologisch besser verträglichen Kon zentrationen einzusetzen. The use of alkyl (oligo) glycosides in the invention Deodorants lead to numerous deodorant agents, e.g. B. for cationic compounds and for the bis-biguanides (e.g. Chlorhexidine gluconate) even increased to a synergistic deodorant effect that allows such deodorant active ingredients in particularly low and physiologically better tolerated con use centers.
Anstelle der Alkylglycoside, bevorzugt aber zusätzlich zu diesen, können auch weitere oberflächenaktive Substanzen eingesetzt werden, bevorzugt sollte aber die Konzentration an Tensiden 10 Gew.-% nicht überschreiten, ihre Konzentration sollte vielmehr so niedrig wie möglich und nur so hoch wie zur stabilen Emulgierung der Deodorant- Wirkstoffe und ggf. der Duftstoffe erforderlich gehalten werden.Instead of the alkyl glycosides, but preferably in addition to these, other surface-active substances can also be used, however, the concentration of surfactants should preferably not be 10% by weight Rather, their concentration should rather be as low as possible and only as high as for the stable emulsification of the deodorant Active ingredients and possibly the fragrances are kept necessary.
Geeignete Co-Tenside sind vor allem nichtionogene Tenside, z. B. An lagerungsprodukte von Ethylenoxid an fettalkohole, Fettsäuren, Fett säurepartialglyceride, Sorbitanfettsäureester oder Methylglucosid- Fettsäureester. Andere geeignete nichtionische Co-Tenside sind z. B. ethoxyliertes Rizinusöl oder Fettsäureester von Glycerin-ethoxylaten (z. B. Cetiol®HE, Henkel KGaA).Suitable co-surfactants are especially non-ionic surfactants, e.g. B. An storage products from ethylene oxide to fatty alcohols, fatty acids, fat acid partial glycerides, sorbitan fatty acid esters or methyl glucoside Fatty acid esters. Other suitable nonionic co-surfactants are e.g. B. ethoxylated castor oil or fatty acid esters of glycerol ethoxylates (e.g. Cetiol®HE, Henkel KGaA).
Als deodorierende Wirkstoffe können grundsätzlich alle für diesen Zweck bekannten Stoffe eingesetzt werden, die aufgrund ihrer anti mikrobiellen oder esterasehemmenden Wirkung die mikrobielle Schweiß zersetzung auf der Haut hemmen. Es können aber auch adstringierende Stoffe verwendet werden, die einer Schweißbildung auf der Haut ent gegenwirken.In principle, all of these can be used as deodorising agents Purpose known substances are used, which due to their anti microbial or esterase inhibiting effect the microbial sweat Inhibit decomposition on the skin. But it can also be astringent Substances are used that entail perspiration on the skin counteract.
Bekannte adstringierende, schon in geringen Konzentrationen keimhem mende und in höheren Konzentrationen schweißhemmende Verbindungen sind z. B. die im wäßrigen Medium stark hydrolysierenden Aluminium-, Zink- und Zirkoniumsalze.Known astringent, germ-resistant even in low concentrations antiperspirant compounds and in higher concentrations are z. B. the strongly hydrolyzing aluminum in the aqueous medium, Zinc and zirconium salts.
Bekannte esterasehemmende Deodorant-Wirkstoffe sind z. B. die Ester von Hydroxycarbonsäuren wie z. B. Ethyllactat oder Triethylcitrat. Weitere geeignete Wirkstoffe dieses Typs sind z. B. die aus DE-A-43 43 264 und DE-A-43 43 265 bekannten Esterverbindungen.Known esterase-inhibiting deodorant active ingredients are e.g. B. the esters of hydroxycarboxylic acids such as. B. ethyl lactate or triethyl citrate. Other suitable active substances of this type are e.g. B. from DE-A-43 43 264 and DE-A-43 43 265 known ester compounds.
Bekannte antimikrobielle Deodorant-Wirkstoffe sind z. B. die Salze der Benzoesäure, der p-Hydroxybenzoesäure, der Salicylsäure, der Usninsäure oder der Undecylensäure. Weitere geeignete deodorierende Wirkstoffe sind Benzylalkohol, 2-Phenylethanol, Phenoxyethanol, Far nesol, Glycerinmonoalkyl-(C₈-C₁₆)-ether und Diglycerinmonoalkyl- (C₈-C₁₆)-ether und Fettsäuremonoglyceride.Known antimicrobial deodorant active ingredients are e.g. B. the salts benzoic acid, p-hydroxybenzoic acid, salicylic acid, the Usnic acid or undecylenic acid. Other suitable deodorant Active ingredients are benzyl alcohol, 2-phenylethanol, phenoxyethanol, Far nesol, glycerol monoalkyl (C₈-C₁₆) ether and diglycerol monoalkyl (C₈-C₁₆) ether and fatty acid monoglycerides.
Antimikrobielle und esterasehemmende Deodorant-Wirkstoffe sind zur Ausführung der Erfindung in einer Menge von 0,1 bis 2 Gew.-% bevor zugt. Eine bevorzugte Gruppe antimikrobieller und deodorierender Verbindungen ist die der quartären Ammoniumverbindungen, der Bis biguanide, z. B. Chlorhexidin, und der Polybiguanide. Besonders be vorzugt zur Anwendung in den erfindungsgemäßen Körperdeodorantien eignet sich die Gruppe der Betaine und der kationischen Phospholi pide. Insbesondere sind die aus WO 93/25185 als Deodorant-Wirkstoffe bekannten kationischen Phospholipide der Formel II geeignet,Antimicrobial and esterase-inhibiting deodorant active ingredients are used Before carrying out the invention in an amount of 0.1 to 2 wt .-% moves. A preferred group of antimicrobial and deodorant Compounds is that of the quaternary ammonium compounds, the bis biguanides, e.g. B. chlorhexidine, and the polybiguanides. Especially be preferred for use in the body deodorants according to the invention the group of betaines and cationic phospholi is suitable pide. In particular, those from WO 93/25185 are deodorant active ingredients known cationic phospholipids of formula II,
in der R² eine Alkyl-, Alkenyl- oder Hydroxyalkylgruppe mit 8 bis 22 C-Atomen oder eine Acylaminoalkylgruppe der Formel R⁵CONH(CmH2m)- ist, worin R⁵CO eine lineare Acylgruppe mit 8 bis 22 C-Atomen und m = 2 oder 3 ist, R³ und R⁴ Alkylgruppen mit 1 bis 4 C-Atomen oder Hydroxyalkylgruppen mit 2 bis 4 C-Atomen oder Carboxyalkylgruppen der Formel - (CH₂)z - COOM sind, worin x einen Wert von 1 bis 3 und y einen Wert von (3-x) hat und z einen Wert von 1 bis 3 hat, M = Wasserstoff oder ein Alkalimetall oder Ammonium und A ein wasserlös liches Anion ist. Als "wasserlösliches" Anion soll ein Anion ver standen werden, das ein wasserlösliches Ammoniumsalz bildet. Bevor zugt ist A ein Halogenid, z. B. ein Chlorid oder Bromidanion. in which R² is an alkyl, alkenyl or hydroxyalkyl group with 8 to 22 C atoms or an acylaminoalkyl group of the formula R⁵CONH (C m H 2m ) -, in which R⁵CO is a linear acyl group with 8 to 22 C atoms and m = 2 or 3 is, R³ and R⁴ are alkyl groups with 1 to 4 C atoms or hydroxyalkyl groups with 2 to 4 C atoms or carboxyalkyl groups of the formula - (CH₂) z - COOM, where x is a value from 1 to 3 and y is a value of ( 3-x) and z has a value from 1 to 3, M = hydrogen or an alkali metal or ammonium and A is a water-soluble anion. Anion which forms a water-soluble ammonium salt is to be understood as a "water-soluble" anion. Before A is added a halide, e.g. B. a chloride or bromide anion.
Die erfindungsgemäßen Körperdeodorants enthalten zur Einstellung eines pH-Wertes von 3 bis 6 bevorzugt eine schwache Säure wie z. B. Milchsäure, Citronensäure, Weinsäure oder Glycolsäure oder ein Puf fersystem aus solchen Säuren und geringen Mengen der Alkalisalze solcher Säuren.The body deodorants according to the invention contain for adjustment a pH of 3 to 6 preferably a weak acid such as. B. Lactic acid, citric acid, tartaric acid or glycolic acid or a puf system from such acids and small amounts of alkali salts such acids.
Bevorzugt enthalten deodorierende Zubereitungen auch einen Duft stoff, der in Mengen von 0,1 bis 2 Gew.-% zugesetzt werden kann. Auf Duftstoffe kann jedoch auch verzichtet werden, wenn z. B. als Deo dorant-Wirkstoff ein antimikrobiell wirksames ätherisches Öl oder ein antimikrobieller Deodorant-Wirkstoff mit angenehmen Geruch wie z. B. Phenylethylalkohol oder Hydrozimtalkohol oder ein Gemisch ein gesetzt wird, wie es z. B. aus DE-A-41 24 664 bekannt ist.Deodorant preparations preferably also contain a fragrance substance that can be added in amounts of 0.1 to 2 wt .-%. On However, fragrances can also be dispensed with if, for. B. as a deodorant dorant active ingredient an antimicrobial essential oil or an antimicrobial deodorant ingredient with a pleasant smell like e.g. B. phenylethyl alcohol or hydrocinnamic alcohol or a mixture is set as z. B. is known from DE-A-41 24 664.
Die erfindungsgemäßen Körperdeodorantien sind flüssig, d. h. sie sollten bei 20°C eine Viskosität aufweisen, die unterhalb von 1000 [m·Pa·s] liegt (gemessen mit einem Rotationsviskosimeter bei niedri ger Schergeschwindigkeit). Sie eignen sich dann besonders gut zur Anwendung in sogenannten Rollkugel-Auftragsbehältern oder Pumpzer stäubern.The body deodorants according to the invention are liquid, i.e. H. she should have a viscosity at 20 ° C that is below 1000 [m · Pa · s] (measured with a rotary viscometer at low low shear rate). Then they are particularly suitable for Use in so-called roller ball application containers or pumpers dust.
Zur Anwendung in Rollkugel-Auftragsbehältern sollte die Viskosität bevorzugt im Bereich von 500 bis 1000 [m·Pa·s] bei 20°C liegen, was gegebenenfalls durch Zusatz wasserlöslicher Verdickungsmittel, z. B. von natürlichen mikrobiellen oder synthetischen wasserlöslichen Po lymeren wie z. B. wasserlöslicher Stärke, Guar, Xanthan-Gum, Hydroxy ethylcellulose, Hydroxypropylstärke, Polyacrylamid, Polyvinylpyrro lidon, Polyvinylalkohol oder vernetzter Polyacrylate (z. B. des Typs Carbopol®) erreicht werden kann.Viscosity should be used in rollerball application containers preferably in the range from 500 to 1000 [m · Pa · s] at 20 ° C, which optionally by adding water-soluble thickeners, e.g. B. of natural microbial or synthetic water-soluble buttocks lyers such as B. water-soluble starch, guar, xanthan gum, hydroxy ethyl cellulose, hydroxypropyl starch, polyacrylamide, polyvinyl pyrro lidon, polyvinyl alcohol or cross-linked polyacrylates (e.g. of the type Carbopol®) can be achieved.
Zur Anwendung aus Pumpzerstäubern sollte die Viskosität niedriger, bevorzugt unter 500 m·Pa·s (20°C) liegen. For application from pump atomizers, the viscosity should be lower, are preferably below 500 m · Pa · s (20 ° C).
Zusätzlich zu den genannten Komponenten können die erfindungsgemäßen Körperdeodorantien noch weitere in solchen Zubereitungen üblichen Hilfsmittel und Zusätze enthalten. Solche Hilfsmittel sind z. B.In addition to the components mentioned, the inventive Body deodorants are even more common in such preparations Tools and additives included. Such tools are e.g. B.
- - Antioxydantien, z. B. Butylhydroxyanisol, Butylhydroxytoluol, Tocopherole oder Tocopherol-Ester- Antioxidants, e.g. B. butylated hydroxyanisole, butylated hydroxytoluene, Tocopherols or tocopherol esters
- - Komplexbildner, z. B. Ethylendiamin-tetraessigsäure-Salze, Ni trilotriessigsäure-Salze, Na-Citrat- Complexing agents, e.g. B. ethylenediamine tetraacetic acid salts, Ni trilotriacetic acid salts, sodium citrate
- - Hautkosmetische Wirkstoffe, z. B. Ölkomponenten, Fette, Wachse, Paraffine, Silikone in geringen Mengen von bis zu 2 Gew.-% der Zubereitung- Skin cosmetic active ingredients, e.g. B. oil components, fats, waxes, Paraffins, silicones in small amounts of up to 2% by weight preparation
- - Hilfsmittel zur Vermittlung eines Frischegefühls auf der Haut, z. B. Menthol oder Mentyllactat- Aids to convey a feeling of freshness on the skin, e.g. B. menthol or mentyl lactate
- - Farbstoffe, Trübungsmittel.- dyes, opacifiers.
Die folgenden Beispiele sollen den Patentgegenstand näher erläutern:The following examples are intended to explain the subject matter of the patent in more detail:
Claims (7)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1995119404 DE19519404A1 (en) | 1995-05-26 | 1995-05-26 | Body deodorant |
| EP96917381A EP0828476A2 (en) | 1995-05-26 | 1996-05-17 | Body deodorant |
| PCT/EP1996/002108 WO1996037184A2 (en) | 1995-05-26 | 1996-05-17 | Body deodorant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1995119404 DE19519404A1 (en) | 1995-05-26 | 1995-05-26 | Body deodorant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE19519404A1 true DE19519404A1 (en) | 1996-11-28 |
Family
ID=7762973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1995119404 Withdrawn DE19519404A1 (en) | 1995-05-26 | 1995-05-26 | Body deodorant |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0828476A2 (en) |
| DE (1) | DE19519404A1 (en) |
| WO (1) | WO1996037184A2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19917743A1 (en) * | 1999-04-20 | 2000-10-26 | Cognis Deutschland Gmbh | Synergistic cosmetic deodorant preparation containing beta-(1,3)-glucan, aluminum chlorohydrate and esterase inhibitor and/or bactericidal/bacteriostatic agent |
| EP1068862A3 (en) * | 1999-05-28 | 2001-11-28 | Wella Aktiengesellschaft | Deodorizing combination of active substances and its use |
| WO2005105026A1 (en) * | 2004-04-27 | 2005-11-10 | Beiersdorf Ag | Transparent cosmetic or dermatological formulation |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102010028420A1 (en) | 2010-04-30 | 2011-11-03 | Henkel Ag & Co. Kgaa | Deo foams |
| MX351390B (en) | 2013-03-12 | 2017-10-12 | Procter & Gamble | Methods of making solid stick antiperspirant compositions. |
| US9717930B2 (en) | 2013-03-12 | 2017-08-01 | The Procter & Gamble Company | Antiperspirant compositions |
| MX386984B (en) | 2014-06-30 | 2025-03-19 | Procter & Gamble | METHOD FOR MANUFACTURING A STICK THAT INCLUDES ANTIPERSPIRANT. |
| MX360041B (en) | 2014-06-30 | 2018-10-18 | Procter & Gamble | Personal care compositions and methods. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4305996C1 (en) * | 1993-02-26 | 1994-03-31 | Goldwell Ag | Permanent hair styling agent - contg. lower alkyl citric acid ester, reducing thio cpd. and an alkalisation agent. |
-
1995
- 1995-05-26 DE DE1995119404 patent/DE19519404A1/en not_active Withdrawn
-
1996
- 1996-05-17 EP EP96917381A patent/EP0828476A2/en not_active Withdrawn
- 1996-05-17 WO PCT/EP1996/002108 patent/WO1996037184A2/en not_active Ceased
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19917743A1 (en) * | 1999-04-20 | 2000-10-26 | Cognis Deutschland Gmbh | Synergistic cosmetic deodorant preparation containing beta-(1,3)-glucan, aluminum chlorohydrate and esterase inhibitor and/or bactericidal/bacteriostatic agent |
| DE19917743C2 (en) * | 1999-04-20 | 2003-08-14 | Biotec Asa | Deodorising preparations |
| EP1068862A3 (en) * | 1999-05-28 | 2001-11-28 | Wella Aktiengesellschaft | Deodorizing combination of active substances and its use |
| WO2005105026A1 (en) * | 2004-04-27 | 2005-11-10 | Beiersdorf Ag | Transparent cosmetic or dermatological formulation |
| CN1946369B (en) * | 2004-04-27 | 2012-11-28 | 拜尔斯道夫股份有限公司 | Transparent cosmetic or dermatological preparation |
| US8747821B2 (en) | 2004-04-27 | 2014-06-10 | Beiersdorf Ag | Transparent cosmetic or dermatological formulation |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0828476A2 (en) | 1998-03-18 |
| WO1996037184A3 (en) | 1997-01-23 |
| WO1996037184A2 (en) | 1996-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0689418B1 (en) | Deodorant active-substance combinations made from wool-grease acids and partial glycerides | |
| EP1652431B1 (en) | Agents having a controlled sustained release to combat microorganisms | |
| DE102010028420A1 (en) | Deo foams | |
| DE102017201025A1 (en) | "Cosmetic compositions containing a combination of at least two different active substances" | |
| DE19519404A1 (en) | Body deodorant | |
| EP3209387B1 (en) | Use of chitosans in antiperspirant compositions free of halogen or halogenhydroxysalts of aluminum and or zirconium | |
| EP3212156B1 (en) | Cosmetic antiperspirant composition | |
| EP1250842A1 (en) | Composition for controlling microorganisms containing an effective amount of polyglycerinesters | |
| EP2033622B1 (en) | Cosmetic cleaning products with a low pH | |
| DE102016221154A1 (en) | Cosmetic compositions containing a combination of at least two different active ingredients | |
| EP3452006B1 (en) | Antiperspirant composition | |
| DE102014216913A1 (en) | Antiperspirant cosmetic products containing mallow family fruits of the genus Adansonia which do not contain halides and / or hydroxy halides of aluminum and / or zirconium | |
| WO2013092114A2 (en) | Deodorants and antiperspirants having stabilized antioxidant | |
| DE102016221155A1 (en) | Cosmetic compositions containing a combination of at least two different active ingredients | |
| EP1040757B1 (en) | Antiseptic/antifungal agent and endermic liniment composition which contains it | |
| JP2002226355A (en) | Liquid composition for sheet-like cosmetic and sheet-like cosmetic in which the same composition is impregnated | |
| DE10047759A1 (en) | Cloths or tissues for use in body deodorizing are impregnated with composition containing enzyme-inhibiting ester and antimicrobial diol | |
| JP2000264830A (en) | Cosmetic composition | |
| WO2016030060A1 (en) | Anti body odor preparations which are low in electrolytes | |
| DE102005029385A1 (en) | Active ingredient combinations of glycopyrronium bromide and mono-, oligo- and / or polysaccharides | |
| DE102013223657A1 (en) | Kit for the production of Bispyridiniumalkan containing foams | |
| DE102021203720A1 (en) | Clear, skin-friendly deodorants or antiperspirants | |
| DE102019133191A1 (en) | Soluble oligomers of propanediol as an active ingredient to regulate sweat secretion | |
| FR3090344A1 (en) | Kosmetische Mittel, enthaltend eine Kombination von mindestens zwei verschiedenen Wirkstoffen | |
| EP3793509A1 (en) | Method for reducing perspiration with malonic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8139 | Disposal/non-payment of the annual fee |